111 related articles for article (PubMed ID: 28490183)
1. Clinical utility of measuring both glutamic acid decarboxylase antibodies and islet cell antibodies in the diagnosis of latent autoimmune diabetes in adults - is it cost-effective?
Hughes LE; Ford C; Ekbote A; Gama R
Ann Clin Biochem; 2017 Sep; 54(5):623-624. PubMed ID: 28490183
[No Abstract] [Full Text] [Related]
2. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
[TBL] [Abstract][Full Text] [Related]
3. A decrease in glutamic acid decarboxylase autoantibody levels with sitagliptin use in patients with latent autoimmune diabetes in adults.
Yanai H
Diabetes Metab; 2018 Mar; 44(2):188-189. PubMed ID: 28571922
[No Abstract] [Full Text] [Related]
4. Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up.
Huang G; Yin M; Xiang Y; Li X; Shen W; Luo S; Lin J; Xie Z; Zheng P; Zhou Z
Diabetes Metab Res Rev; 2016 Sep; 32(6):615-22. PubMed ID: 26787598
[TBL] [Abstract][Full Text] [Related]
5. [Vaccine for prevention of type 1 diabetes mellitus].
Surković I; Suljević I; Ascić-Buturović B; Heljić B
Med Arh; 2006; 60(3):198-9. PubMed ID: 16719238
[TBL] [Abstract][Full Text] [Related]
6. Associated autoimmunity in Type 1 Diabetes and latent autoimmune diabetes of adults: The role of glutamic-acid decarboxylase autoantibodies.
Gougourelas D; Tsentidis C; Koufadaki AM; Koutsovasilis A; Gougourela E; Karanasios S; Sotiropoulos A; Bousboulas S; Karavanaki KA
Diabetes Res Clin Pract; 2021 May; 175():108847. PubMed ID: 33945840
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestation and islet β-cell function of a subtype of latent autoimmune diabetes in adults (LADA): positive for T cell responses in phenotypic type 2 diabetes.
Liang H; Cheng Y; Tang W; Cui Q; Yuan J; Huang G; Yang L; Zhou Z
Acta Diabetol; 2019 Nov; 56(11):1225-1230. PubMed ID: 31367990
[TBL] [Abstract][Full Text] [Related]
8. [Features of the development of latent autoimmune diabetes in adults (LADA)].
Timakova AA; Saltykov BB
Arkh Patol; 2019; 81(4):78-82. PubMed ID: 31407723
[TBL] [Abstract][Full Text] [Related]
9. Common autoimmune biomarkers, thyroid hormonal abnormalities, and beta cells dysfunction in patients with latent autoimmune diabetes in adults with type II diabetes mellitus.
Yousefzadeh G; Gozashti M; Najafipour H; Gholamhosseinian NA; Bahramnejad A; Shokouhi M
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S52-5. PubMed ID: 27094870
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood mononuclear cells of patients with latent autoimmune diabetes secrete higher levels of pro- & anti-inflammatory cytokines compared to those with type-1 diabetes mellitus following
Badal D; Kumar R; Paul M; Dayal D; Bhansali A; Bhadada SK; Kumar R; Sachdeva N
Indian J Med Res; 2017 Jun; 145(6):767-776. PubMed ID: 29067979
[TBL] [Abstract][Full Text] [Related]
11. Latent autoimmune diabetes and limbic encephalitis with antibodies against glutamic acid decarboxylase.
Popkirov S; Sebastian S; Ismail FS; Wellmer J
J Diabetes; 2018 Apr; 10(4):338-340. PubMed ID: 29154389
[No Abstract] [Full Text] [Related]
12. [Latent autoimmune diabetes of adults (LADA): The informative value of autoantibodies].
Silko YV; Nikonova TV; Ivanova ON; Stepanova SM; Shestakova MV; Dedov II
Ter Arkh; 2016; 88(10):42-45. PubMed ID: 27801418
[TBL] [Abstract][Full Text] [Related]
13. A high titre of autoantibody at onset does not predict pancreatic beta-cell fate.
Yanai H
Diabetes Metab; 2016 Dec; 42(6):475-476. PubMed ID: 27502116
[No Abstract] [Full Text] [Related]
14. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
[TBL] [Abstract][Full Text] [Related]
15. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6).
Zampetti S; Capizzi M; Spoletini M; Campagna G; Leto G; Cipolloni L; Tiberti C; Bosi E; Falorni A; Buzzetti R;
J Clin Endocrinol Metab; 2012 Oct; 97(10):3759-65. PubMed ID: 22865904
[TBL] [Abstract][Full Text] [Related]
16. Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?
Reinehr T; Schober E; Wiegand S; Thon A; Holl R;
Arch Dis Child; 2006 Jun; 91(6):473-7. PubMed ID: 16449253
[TBL] [Abstract][Full Text] [Related]
17. Negativation of type 1 diabetes-associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol.
Papadimitriou DT; Marakaki C; Fretzayas A; Nicolaidou P; Papadimitriou A
J Diabetes; 2013 Sep; 5(3):344-8. PubMed ID: 23302101
[TBL] [Abstract][Full Text] [Related]
18. [Auto-antibodies against glutamic acid decarboxylase and diabetes].
Mandrup-Poulsen TR
Ugeskr Laeger; 2007 Jan; 169(4):300-4. PubMed ID: 17274923
[TBL] [Abstract][Full Text] [Related]
19. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.
Maioli M; Pes GM; Delitala G; Puddu L; Falorni A; Tolu F; Lampis R; Orrù V; Secchi G; Cicalò AM; Floris R; Madau GF; Pilosu RM; Whalen M; Cucca F
Eur J Endocrinol; 2010 Oct; 163(4):541-9. PubMed ID: 20603341
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of zinc transporter 8 antibodies in gestational diabetes mellitus.
Dereke J; Nilsson C; Landin-Olsson M; Hillman M
Diabet Med; 2012 Dec; 29(12):e436-9. PubMed ID: 22924602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
